FindTrial
Sign In

Immature platelet fraction in children with severe thrombocytopenia

To Study the role of immature platelet fraction in children with severe thrombocytopenia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060625
Enrollment
300
Registered
2023-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Intervention1: NIL: NIL Control Intervention1: nil: nil

Sponsors

MANIPAL ACADEMY OF HIGHER EDUCATION
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases: Children from 1month to 18years of age with severe thrombocytopenia having Platelet count less than 1,00,000 per microlitre. Control: Controls: Children from 1month to 18years of age with platelet counts within normal limits 1,50,000/microlitre to 4,50,000/microlitre

Exclusion criteria

Exclusion criteria: Children diagnosed with haematological malignancies (leukaemia, lymphoma) and currently on anti-cancer drugs. Children previously diagnosed of idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, aplastic anemia on disease specific treatment. Children who had received platelet transfusion in the past 1 month

Design outcomes

Primary

MeasureTime frame
The role of immature platelet fraction in severe thrombocytopenia and its range in paediatrics population in different aetiologies will be analysed at the end of the study after 18 monthsTimepoint: 18 MONTHS—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Aishwarya N

Kasturba Medical college, Manipal, MAHE

sandesh.kini@manipal.edu9731149519

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026